These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 19738367)
41. Beta-amyloid, neuronal death and Alzheimer's disease. Carter J; Lippa CF Curr Mol Med; 2001 Dec; 1(6):733-7. PubMed ID: 11899259 [TBL] [Abstract][Full Text] [Related]
42. Glia-specific APOE epigenetic changes in the Alzheimer's disease brain. Tulloch J; Leong L; Thomson Z; Chen S; Lee EG; Keene CD; Millard SP; Yu CE Brain Res; 2018 Nov; 1698():179-186. PubMed ID: 30081037 [TBL] [Abstract][Full Text] [Related]
43. Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid-β clearance and aggregation in Alzheimer's disease. Liu CC; Zhao N; Yamaguchi Y; Cirrito JR; Kanekiyo T; Holtzman DM; Bu G Sci Transl Med; 2016 Mar; 8(332):332ra44. PubMed ID: 27030596 [TBL] [Abstract][Full Text] [Related]
44. DNA Double-Strand Break Accumulation in Alzheimer's Disease: Evidence from Experimental Models and Postmortem Human Brains. Thadathil N; Delotterie DF; Xiao J; Hori R; McDonald MP; Khan MM Mol Neurobiol; 2021 Jan; 58(1):118-131. PubMed ID: 32895786 [TBL] [Abstract][Full Text] [Related]
45. Tau Positive Neurons Show Marked Mitochondrial Loss and Nuclear Degradation in Alzheimer's Disease. Wee M; Chegini F; Power JHT; Majd S Curr Alzheimer Res; 2018; 15(10):928-937. PubMed ID: 29895248 [TBL] [Abstract][Full Text] [Related]
46. Morphologically distinct types of amyloid plaques point the way to a better understanding of Alzheimer's disease pathogenesis. D'Andrea MR; Nagele RG Biotech Histochem; 2010 Apr; 85(2):133-47. PubMed ID: 20121465 [TBL] [Abstract][Full Text] [Related]
47. TG-1: a marker for neuronal nuclei in Alzheimer's disease. Vincent I; Mattiace LA; Dickson DW; Rosado M; Katen R; Davies P Neurobiol Dis; 1994 Dec; 1(3):145-57. PubMed ID: 9173994 [TBL] [Abstract][Full Text] [Related]
48. The cerebromicrovasculature: a key player in the pathogenesis of Alzheimer's disease. Grammas P; Yamada M; Zlokovic B J Alzheimers Dis; 2002 Jun; 4(3):217-23. PubMed ID: 12226540 [TBL] [Abstract][Full Text] [Related]
49. Shenzao jiannao oral liquid, an herbal formula, ameliorates cognitive impairments by rescuing neuronal death and triggering endogenous neurogenesis in AD-like mice induced by a combination of Aβ42 and scopolamine. Xiao H; Li H; Song H; Kong L; Yan X; Li Y; Deng Y; Tai H; Wu Y; Ni Y; Li W; Chen J; Yang J J Ethnopharmacol; 2020 Sep; 259():112957. PubMed ID: 32416248 [TBL] [Abstract][Full Text] [Related]
50. Mechanisms of action of amyloid-beta and its precursor protein in neuronal cell death. Leong YQ; Ng KY; Chye SM; Ling APK; Koh RY Metab Brain Dis; 2020 Jan; 35(1):11-30. PubMed ID: 31811496 [TBL] [Abstract][Full Text] [Related]
51. Mechanisms of neuronal death in Alzheimer's disease. Cotman CW; Su JH Brain Pathol; 1996 Oct; 6(4):493-506. PubMed ID: 8944319 [TBL] [Abstract][Full Text] [Related]
52. Low Levels of Brain-Derived Neurotrophic Factor Trigger Self-aggregated Amyloid β-Induced Neuronal Cell Death in an Alzheimer's Cell Model. Tagai N; Tanaka A; Sato A; Uchiumi F; Tanuma SI Biol Pharm Bull; 2020; 43(7):1073-1080. PubMed ID: 32612070 [TBL] [Abstract][Full Text] [Related]
53. Conditional neuronal simian virus 40 T antigen expression induces Alzheimer-like tau and amyloid pathology in mice. Park KH; Hallows JL; Chakrabarty P; Davies P; Vincent I J Neurosci; 2007 Mar; 27(11):2969-78. PubMed ID: 17360920 [TBL] [Abstract][Full Text] [Related]
54. DNA polymerase β decrement triggers death of olfactory bulb cells and impairs olfaction in a mouse model of Alzheimer's disease. Misiak M; Vergara Greeno R; Baptiste BA; Sykora P; Liu D; Cordonnier S; Fang EF; Croteau DL; Mattson MP; Bohr VA Aging Cell; 2017 Feb; 16(1):162-172. PubMed ID: 27686631 [TBL] [Abstract][Full Text] [Related]
55. Bim is elevated in Alzheimer's disease neurons and is required for beta-amyloid-induced neuronal apoptosis. Biswas SC; Shi Y; Vonsattel JP; Leung CL; Troy CM; Greene LA J Neurosci; 2007 Jan; 27(4):893-900. PubMed ID: 17251431 [TBL] [Abstract][Full Text] [Related]
56. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases. Mattson MP; Pedersen WA; Duan W; Culmsee C; Camandola S Ann N Y Acad Sci; 1999; 893():154-75. PubMed ID: 10672236 [TBL] [Abstract][Full Text] [Related]
57. Alzheimer's disease neuropathological change and loss of matrix/neuropil in patients with idiopathic Normal Pressure Hydrocephalus, a model of Alzheimer's disease. Libard S; Alafuzoff I Acta Neuropathol Commun; 2019 May; 7(1):98. PubMed ID: 31142354 [TBL] [Abstract][Full Text] [Related]
58. Reducing Endogenous α-Synuclein Mitigates the Degeneration of Selective Neuronal Populations in an Alzheimer's Disease Transgenic Mouse Model. Spencer B; Desplats PA; Overk CR; Valera-Martin E; Rissman RA; Wu C; Mante M; Adame A; Florio J; Rockenstein E; Masliah E J Neurosci; 2016 Jul; 36(30):7971-84. PubMed ID: 27466341 [TBL] [Abstract][Full Text] [Related]
59. In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients. Kubo T; Nishimura S; Kumagae Y; Kaneko I J Neurosci Res; 2002 Nov; 70(3):474-83. PubMed ID: 12391608 [TBL] [Abstract][Full Text] [Related]